Alanine 0 7 0 7 B-clinical_variable
aminotransferase 8 24 8 24 I-clinical_variable
( 25 26 25 26 I-clinical_variable
ALT 26 29 26 29 I-clinical_variable
) 29 30 29 30 I-clinical_variable
or 31 33 31 33 O
aspartate 34 43 34 43 B-clinical_variable
aminotransferase 44 60 44 60 I-clinical_variable
( 61 62 61 62 I-clinical_variable
AST 62 65 62 65 I-clinical_variable
) 65 66 65 66 I-clinical_variable
equal 67 72 67 72 O
or 73 75 73 75 O
less 76 80 76 80 O
than 81 85 81 85 O
200 86 89 86 89 B-upper_bound
IU 90 92 90 92 I-upper_bound
/ 92 93 92 93 I-upper_bound
ml 93 95 93 95 I-upper_bound
for 96 99 96 99 O
adults 100 106 100 106 O

Bilirubin 0 9 107 116 B-clinical_variable
equal 10 15 117 122 O
or 16 18 123 125 O
less 19 23 126 130 O
than 24 28 131 135 O
1.5 29 32 136 139 B-upper_bound
mg 33 35 140 142 I-upper_bound
/ 35 36 142 143 I-upper_bound
dl 36 38 143 145 I-upper_bound
except 39 45 146 152 O
for 46 49 153 156 O
Gilbert 50 57 157 164 B-chronic_disease
's 57 59 164 166 I-chronic_disease
disease 60 67 167 174 I-chronic_disease

Central 0 7 175 182 B-chronic_disease
nervous 8 15 183 190 I-chronic_disease
system 16 22 191 197 I-chronic_disease
( 23 24 198 199 I-chronic_disease
CNS 24 27 199 202 I-chronic_disease
) 27 28 202 203 I-chronic_disease
involvement 29 40 204 215 I-chronic_disease
within 41 47 216 222 O
3 48 49 223 224 B-upper_bound
months 50 56 225 231 I-upper_bound

Chronic 0 7 232 239 B-cancer
myeloid 8 15 240 247 I-cancer
leukemia 16 24 248 256 I-cancer
( 25 26 257 258 I-cancer
CML 26 29 258 261 I-cancer
): 29 31 261 263 I-cancer
a. 32 34 264 266 O
failed 35 41 267 273 O
to 42 44 274 276 O
achieve 45 52 277 284 O
cytogenetic 53 64 285 296 O
remission 65 74 297 306 O
or 75 77 307 309 O
have 78 82 310 314 O
cytogenetic 83 94 315 326 O
relapse 95 102 327 334 O
after 103 108 335 340 O
treatment 109 118 341 350 B-treatment
with 119 123 351 355 O
at 124 126 356 358 O
least 127 132 359 364 O
2 133 134 365 366 B-lower_bound
tyrosine 135 143 367 375 B-treatment
kinase 144 150 376 382 I-treatment
inhibitors 151 161 383 393 I-treatment
, 161 162 393 394 O
or 163 165 395 397 O
b. 166 168 398 400 O
accelerated 169 180 401 412 O
phase 181 186 413 418 O
or 187 189 419 421 O
blast 190 195 422 427 O
phase 196 201 428 433 O
at 202 204 434 436 O
any 205 208 437 440 O
time 209 213 441 445 O

Conjugated 0 10 446 456 B-clinical_variable
( 11 12 457 458 I-clinical_variable
direct 12 18 458 464 I-clinical_variable
) 18 19 464 465 I-clinical_variable
bilirubin 20 29 466 475 I-clinical_variable
less 30 34 476 480 O
than 35 39 481 485 O
2 40 41 486 487 B-upper_bound
x 42 43 488 489 I-upper_bound
upper 44 49 490 495 I-upper_bound
limit 50 55 496 501 I-upper_bound
of 56 58 502 504 I-upper_bound
normal 59 65 505 511 I-upper_bound

Diffusing 0 9 512 521 B-clinical_variable
capacity 10 18 522 530 I-clinical_variable
of 19 21 531 533 I-clinical_variable
the 22 25 534 537 I-clinical_variable
lung 26 30 538 542 I-clinical_variable
for 31 34 543 546 I-clinical_variable
carbon 35 41 547 553 I-clinical_variable
monoxide 42 50 554 562 I-clinical_variable
( 51 52 563 564 I-clinical_variable
DLCO 52 56 564 568 I-clinical_variable
) 56 57 568 569 I-clinical_variable
equal 58 63 570 575 O
or 64 66 576 578 O
greater 67 74 579 586 O
than 75 79 587 591 O
50 80 82 592 594 B-lower_bound
% 82 83 594 595 I-lower_bound
predicted 84 93 596 605 O
corrected 94 103 606 615 O
for 104 107 616 619 O
hemoglobin 108 118 620 630 B-clinical_variable

Human 0 5 631 636 B-chronic_disease
immunodeficiency 6 22 637 653 I-chronic_disease
virus 23 28 654 659 I-chronic_disease
( 29 30 660 661 I-chronic_disease
HIV 30 33 661 664 I-chronic_disease
) 33 34 664 665 I-chronic_disease
positive 35 43 666 674 O
; 43 44 674 675 O
active 45 51 676 682 O
hepatitis 52 61 683 692 B-chronic_disease
B 62 63 693 694 I-chronic_disease
or 64 66 695 697 I-chronic_disease
C 67 68 698 699 I-chronic_disease

Inability 0 9 700 709 O
to 10 12 710 712 O
comply 13 19 713 719 O
with 20 24 720 724 O
medical 25 32 725 732 B-treatment
therapy 33 40 733 740 I-treatment
or 41 43 741 743 O
follow 44 50 744 750 O
- 50 51 750 751 O
up 51 53 751 753 O

Lansky 0 6 754 760 B-clinical_variable
Play 7 11 761 765 I-clinical_variable
- 11 12 765 766 I-clinical_variable
performance 12 23 766 777 I-clinical_variable
scale 24 29 778 783 I-clinical_variable
of 30 32 784 786 O
at 33 35 787 789 O
least 36 41 790 795 O
70 42 44 796 798 B-lower_bound
% 44 45 798 799 I-lower_bound
or 46 48 800 802 O
greater 49 56 803 810 O
( 57 58 811 812 O
age 58 61 812 815 B-age
< 62 63 816 817 O
12 64 66 818 820 B-upper_bound
years 67 72 821 826 I-upper_bound
) 72 73 826 827 O

Left 0 4 828 832 B-clinical_variable
ventricular 5 16 833 844 I-clinical_variable
ejection 17 25 845 853 I-clinical_variable
fraction 26 34 854 862 I-clinical_variable
equal 35 40 863 868 O
or 41 43 869 871 O
greater 44 51 872 879 O
than 52 56 880 884 O
40 57 59 885 887 B-lower_bound
% 59 60 887 888 I-lower_bound

Liver 0 5 889 894 O
cirrhosis 6 15 895 904 B-chronic_disease

Patient 0 7 905 912 O
with 8 12 913 917 O
no 13 15 918 920 O
matched 16 23 921 928 O
related 24 31 929 936 O
donor 32 37 937 942 O
who 38 41 943 946 O
has 42 45 947 950 O
a 46 47 951 952 O
related 48 55 953 960 O
haploidentical 56 70 961 975 O
donor 71 76 976 981 O
identified 77 87 982 992 O
(= 88 90 993 995 O
< 90 91 995 996 O
7/8 92 95 997 1000 B-upper_bound
allele 96 102 1001 1007 O
match 103 108 1008 1013 O
at 109 111 1014 1016 O
the 112 115 1017 1020 O
A 116 117 1021 1022 O
, 117 118 1022 1023 O
B 119 120 1024 1025 O
, 120 121 1025 1026 O
C 122 123 1027 1028 O
, 123 124 1028 1029 O
DR 125 127 1030 1032 O
loci 128 132 1033 1037 O
) 132 133 1037 1038 O
who 134 137 1039 1042 O
is 138 140 1043 1045 O
willing 141 148 1046 1053 O
to 149 151 1054 1056 O
undergo 152 159 1057 1064 O
a 160 161 1065 1066 O
bone 162 166 1067 1071 B-treatment
marrow 167 173 1072 1078 I-treatment
harvest 174 181 1079 1086 I-treatment
and 182 185 1087 1090 O
an 186 188 1091 1093 O
NK 189 191 1094 1096 B-treatment
cell 192 196 1097 1101 I-treatment
collection 197 207 1102 1112 I-treatment
approximately 208 221 1113 1126 O
2 222 223 1127 1128 B-upper_bound
weeks 224 229 1129 1134 I-upper_bound
of 230 232 1135 1137 O
the 233 236 1138 1141 O
recipient 237 246 1142 1151 O
's 246 248 1151 1153 O
admission 249 258 1154 1163 O
for 259 262 1164 1167 O
transplant 263 273 1168 1178 B-treatment
; 273 274 1178 1179 O
the 275 278 1180 1183 O
donor 279 284 1184 1189 O
must 285 289 1190 1194 O
be 290 292 1195 1197 O
16 293 295 1198 1200 B-lower_bound
years 296 301 1201 1206 I-lower_bound
of 302 304 1207 1209 O
age 305 308 1210 1213 B-age
or 309 311 1214 1216 O
older 312 317 1217 1222 O
and 318 321 1223 1226 O
weigh 322 327 1227 1232 O
at 328 330 1233 1235 O
least 331 336 1236 1241 O
110 337 340 1242 1245 B-lower_bound
pounds 341 347 1246 1252 I-lower_bound

Patients 0 8 1253 1261 O
with 9 13 1262 1266 O
myelodysplastic 14 29 1267 1282 B-cancer
syndromes 30 39 1283 1292 I-cancer
( 40 41 1293 1294 I-cancer
MDS 41 44 1294 1297 I-cancer
): 44 46 1297 1299 I-cancer
a. 47 49 1300 1302 O
de 50 52 1303 1305 O
novo 53 57 1306 1310 O
MDS 58 61 1311 1314 O
with 62 66 1315 1319 O
intermediate 67 79 1320 1332 O
or 80 82 1333 1335 O
high 83 87 1336 1340 O
- 87 88 1340 1341 O
risk 88 92 1341 1345 O
International 93 106 1346 1359 O
Prognostic 107 117 1360 1370 O
Scoring 118 125 1371 1378 O
System 126 132 1379 1385 O
( 133 134 1386 1387 O
IPSS 134 138 1387 1391 O
) 138 139 1391 1392 O
scores 140 146 1393 1399 O
; 146 147 1399 1400 O
patients 148 156 1401 1409 O
with 157 161 1410 1414 O
intermediate-1 162 176 1415 1429 O
features 177 185 1430 1438 O
should 186 192 1439 1445 O
have 193 197 1446 1450 O
failed 198 204 1451 1457 O
to 205 207 1458 1460 O
respond 208 215 1461 1468 O
to 216 218 1469 1471 O
hypomethylating 219 234 1472 1487 B-treatment
agent 235 240 1488 1493 I-treatment
therapy 241 248 1494 1501 I-treatment
, 248 249 1501 1502 O
or 250 252 1503 1505 O
b. 253 255 1506 1508 O
patients 256 264 1509 1517 O
with 265 269 1518 1522 O
treatment 270 279 1523 1532 O
- 279 280 1532 1533 O
related 280 287 1533 1540 O
MDS 288 291 1541 1544 O

Performance 0 11 1545 1556 B-clinical_variable
score 12 17 1557 1562 I-clinical_variable
of 18 20 1563 1565 O
at 21 23 1566 1568 O
least 24 29 1569 1574 O
70 30 32 1575 1577 B-lower_bound
% 32 33 1577 1578 I-lower_bound
by 34 36 1579 1581 O
Karnofsky 37 46 1582 1591 B-clinical_variable
or 47 49 1592 1594 O
0 50 51 1595 1596 O
to 52 54 1597 1599 O
1 55 56 1600 1601 B-upper_bound
by 57 59 1602 1604 O
Eastern 60 67 1605 1612 B-clinical_variable
Cooperative 68 79 1613 1624 I-clinical_variable
Oncology 80 88 1625 1633 I-clinical_variable
Group 89 94 1634 1639 I-clinical_variable
( 95 96 1640 1641 I-clinical_variable
ECOG 96 100 1641 1645 I-clinical_variable
) 100 101 1645 1646 I-clinical_variable
( 102 103 1647 1648 O
age 103 106 1648 1651 B-age
> 107 108 1652 1653 O
= 108 109 1653 1654 O
12 110 112 1655 1657 B-lower_bound
years 113 118 1658 1663 I-lower_bound
) 118 119 1663 1664 O

Positive 0 8 1665 1673 B-pregnancy
pregnancy 9 18 1674 1683 I-pregnancy
test 19 23 1684 1688 O
in 24 26 1689 1691 O
a 27 28 1692 1693 O
woman 29 34 1694 1699 B-gender
with 35 39 1700 1704 O
child 40 45 1705 1710 O
bearing 46 53 1711 1718 O
potential 54 63 1719 1728 O
defined 64 71 1729 1736 O
as 72 74 1737 1739 O
not 75 78 1740 1743 O
post 79 83 1744 1748 O
- 83 84 1748 1749 O
menopausal 84 94 1749 1759 O
for 95 98 1760 1763 O
12 99 101 1764 1766 B-upper_bound
months 102 108 1767 1773 I-upper_bound
or 109 111 1774 1776 O
no 112 114 1777 1779 O
previous 115 123 1780 1788 O
surgical 124 132 1789 1797 B-treatment
sterilization 133 146 1798 1811 I-treatment

Serum 0 5 1812 1817 B-clinical_variable
creatinine 6 16 1818 1828 I-clinical_variable
clearance 17 26 1829 1838 I-clinical_variable
equal 27 32 1839 1844 O
or 33 35 1845 1847 O
more 36 40 1848 1852 O
than 41 45 1853 1857 O
50 46 48 1858 1860 B-upper_bound
ml 49 51 1861 1863 I-upper_bound
/ 51 52 1863 1864 I-upper_bound
min 52 55 1864 1867 I-upper_bound
( 56 57 1868 1869 O
calculated 57 67 1869 1879 O
with 68 72 1880 1884 O
Cockcroft 73 82 1885 1894 B-clinical_variable
- 82 83 1894 1895 I-clinical_variable
Gault 83 88 1895 1900 I-clinical_variable
formula 89 96 1901 1908 I-clinical_variable
) 96 97 1908 1909 O

Uncontrolled 0 12 1910 1922 B-chronic_disease
infections 13 23 1923 1933 I-chronic_disease
; 23 24 1933 1934 O
principal 25 34 1935 1944 O
investigator 35 47 1945 1957 O
( 48 49 1958 1959 O
PI 49 51 1959 1961 O
) 51 52 1961 1962 O
is 53 55 1963 1965 O
the 56 59 1966 1969 O
final 60 65 1970 1975 O
arbiter 66 73 1976 1983 O
of 74 76 1984 1986 O
this 77 81 1987 1991 O
criterion 82 91 1992 2001 O

acute 0 5 2002 2007 B-cancer
myeloid 6 13 2008 2015 I-cancer
leukemia 14 22 2016 2024 I-cancer
( 23 24 2025 2026 I-cancer
AML 24 27 2026 2029 I-cancer
): 27 29 2029 2031 I-cancer
a. 30 32 2032 2034 O
first 33 38 2035 2040 O
complete 39 47 2041 2049 O
remission 48 57 2050 2059 O
with 58 62 2060 2064 O
high 63 67 2065 2069 O
- 67 68 2069 2070 O
risk 68 72 2070 2074 O
features 73 81 2075 2083 O
defined 82 89 2084 2091 O
as 90 92 2092 2094 O
: 92 93 2094 2095 O
( 94 95 2096 2097 O
i 95 96 2097 2098 O
) 96 97 2098 2099 O
greater 98 105 2100 2107 O
than 106 110 2108 2112 O
1 111 112 2113 2114 B-lower_bound
cycle 113 118 2115 2120 I-lower_bound
of 119 121 2121 2123 O
induction 122 131 2124 2133 B-treatment
therapy 132 139 2134 2141 I-treatment
required 140 148 2142 2150 O
to 149 151 2151 2153 O
achieve 152 159 2154 2161 O
remission 160 169 2162 2171 O
; 169 170 2171 2172 O
( 171 172 2173 2174 O
ii 172 174 2174 2176 O
) 174 175 2176 2177 O
preceding 176 185 2178 2187 O
myelodysplastic 186 201 2188 2203 B-cancer
syndrome 202 210 2204 2212 I-cancer
( 211 212 2213 2214 I-cancer
MDS 212 215 2214 2217 I-cancer
) 215 216 2217 2218 I-cancer
; 216 217 2218 2219 O
( 218 219 2220 2221 O
iii 219 222 2221 2224 O
) 222 223 2224 2225 O
presence 224 232 2226 2234 O
of 233 235 2235 2237 O
FLT3 236 240 2238 2242 B-cancer
mutations 241 250 2243 2252 I-cancer
or 251 253 2253 2255 O
internal 254 262 2256 2264 O
tandem 263 269 2265 2271 O
duplication 270 281 2272 2283 O
or 282 284 2284 2286 O
other 285 290 2287 2292 O
mutations 291 300 2293 2302 O
associated 301 311 2303 2313 O
with 312 316 2314 2318 O
poor 317 321 2319 2323 O
- 321 322 2323 2324 O
risk 322 326 2324 2328 O
AML 327 330 2329 2332 O
( 331 332 2333 2334 O
e.g. 332 336 2334 2338 O
DNMT3A 337 343 2339 2345 O
, 343 344 2345 2346 O
TET2 345 349 2347 2351 O
) 349 350 2351 2352 O
; 350 351 2352 2353 O
( 352 353 2354 2355 O
iv 353 355 2355 2357 O
) 355 356 2357 2358 O
French 357 363 2359 2365 B-clinical_variable
- 363 364 2365 2366 I-clinical_variable
American 364 372 2366 2374 I-clinical_variable
- 372 373 2374 2375 I-clinical_variable
British 373 380 2375 2382 I-clinical_variable
Classification 381 395 2383 2397 I-clinical_variable
( 396 397 2398 2399 I-clinical_variable
FAB 397 400 2399 2402 I-clinical_variable
) 400 401 2402 2403 I-clinical_variable
M6 402 404 2404 2406 B-lower_bound
or 405 407 2407 2409 O
M7 408 410 2410 2412 B-upper_bound
classification 411 425 2413 2427 O
; 425 426 2427 2428 O
( 427 428 2429 2430 O
v 428 429 2430 2431 O
) 429 430 2431 2432 O
adverse 431 438 2433 2440 O
cytogenetics 439 451 2441 2453 O
: 451 452 2453 2454 O
-5 453 455 2455 2457 O
, 455 456 2457 2458 O
deletion 457 465 2459 2467 O
( 466 467 2468 2469 O
del 467 470 2469 2472 O
) 470 471 2472 2473 O
5q 472 474 2474 2476 O
, 474 475 2476 2477 O
-7 476 478 2478 2480 O
, 478 479 2480 2481 O
del7q 480 485 2482 2487 O
, 485 486 2487 2488 O
abnormalities 487 500 2489 2502 O
involving 501 510 2503 2512 O
3q 511 513 2513 2515 O
, 513 514 2515 2516 O
9q 515 517 2517 2519 O
, 517 518 2519 2520 O
11q 519 522 2521 2524 O
, 522 523 2524 2525 O
20q 524 527 2526 2529 O
, 527 528 2529 2530 O
21q 529 532 2531 2534 O
, 532 533 2534 2535 O
17 534 536 2536 2538 O
, 536 537 2538 2539 O
+8 538 540 2540 2542 O
or 541 543 2543 2545 O
complex 544 551 2546 2553 B-clinical_variable
karyotype 552 561 2554 2563 I-clinical_variable
( 562 563 2564 2565 O
> 563 564 2565 2566 O
3 565 566 2567 2568 O
abnormalities 567 580 2569 2582 O
) 580 581 2582 2583 O
; 581 582 2583 2584 O
( 583 584 2585 2586 O
vi 584 586 2586 2588 O
) 586 587 2588 2589 O
treatment 588 597 2590 2599 B-cancer
- 597 598 2599 2600 I-cancer
related 598 605 2600 2607 I-cancer
AML 606 609 2608 2611 I-cancer
, 609 610 2611 2612 O
or 611 613 2613 2615 O
b. 614 616 2616 2618 O
second 617 623 2619 2625 O
or 624 626 2626 2628 O
greater 627 634 2629 2636 O
remission 635 644 2637 2646 O
; 644 645 2646 2647 O
patients 646 654 2648 2656 O
beyond 655 661 2657 2663 O
second 662 668 2664 2670 O
remission 669 678 2671 2680 O
have 679 683 2681 2685 O
to 684 686 2686 2688 O
be 687 689 2689 2691 O
in 690 692 2692 2694 O
complete 693 701 2695 2703 O
remission 702 711 2704 2713 O
( 712 713 2714 2715 O
CR 713 715 2715 2717 O
) 715 716 2717 2718 O
at 717 719 2719 2721 O
transplant 720 730 2722 2732 O
to 731 733 2733 2735 O
be 734 736 2736 2738 O
eligible 737 745 2739 2747 O
, 745 746 2747 2748 O
or 747 749 2749 2751 O
c. 750 752 2752 2754 O
primary 753 760 2755 2762 O
induction 761 770 2763 2772 O
failure 771 778 2773 2780 O
with 779 783 2781 2785 O
partial 784 791 2786 2793 O
response 792 800 2794 2802 O
to 801 803 2803 2805 O
therapy 804 811 2806 2813 O
who 812 815 2814 2817 O
achieve 816 823 2818 2825 O
adequate 824 832 2826 2834 B-treatment
cytoreduction 833 846 2835 2848 I-treatment

assent 0 6 2849 2855 O
of 7 9 2856 2858 O
a 10 11 2859 2860 O
minor 12 17 2861 2866 O
if 18 20 2867 2869 O
participant 21 32 2870 2881 O
's 32 34 2881 2883 O
age 35 38 2884 2887 B-age
is 39 41 2888 2890 O
at 42 44 2891 2893 O
least 45 50 2894 2899 O
seven 51 56 2900 2905 B-lower_bound
and 57 60 2906 2909 O
less 61 65 2910 2914 O
than 66 70 2915 2919 O
eighteen 71 79 2920 2928 B-upper_bound
years 80 85 2929 2934 I-upper_bound

children 0 8 2935 2943 O
= 9 10 2944 2945 O
< 10 11 2945 2946 O
7 12 13 2947 2948 B-upper_bound
years 14 19 2949 2954 I-upper_bound
of 20 22 2955 2957 O
age 23 26 2958 2961 B-age
who 27 30 2962 2965 O
are 31 34 2966 2969 O
unable 35 41 2970 2976 O
to 42 44 2977 2979 O
perform 45 52 2980 2987 O
pulmonary 53 62 2988 2997 B-treatment
function 63 71 2998 3006 I-treatment
tests 72 77 3007 3012 I-treatment
( 78 79 3013 3014 I-treatment
PFT 79 82 3014 3017 I-treatment
) 82 83 3017 3018 I-treatment

oxygen 0 6 3019 3025 B-clinical_variable
saturation 7 17 3026 3036 I-clinical_variable
> 18 19 3037 3038 O
= 19 20 3038 3039 O
92 21 23 3040 3042 B-lower_bound
% 23 24 3042 3043 I-lower_bound
on 25 27 3044 3046 O
room 28 32 3047 3051 O
air 33 36 3052 3055 O
by 37 39 3056 3058 O
pulse 40 45 3059 3064 O
oximetry 46 54 3065 3073 O

patients 0 8 3074 3082 O
age 9 12 3083 3086 B-age
2 13 14 3087 3088 B-lower_bound
- 14 15 3088 3089 O
17 15 17 3089 3091 B-upper_bound
years 18 23 3092 3097 I-upper_bound
old 24 27 3098 3101 O
may 28 31 3102 3105 O
be 32 34 3106 3108 O
enrolled 35 43 3109 3117 O
after 44 49 3118 3123 O
at 50 52 3124 3126 O
least 53 58 3127 3132 O
4 59 60 3133 3134 B-lower_bound
adults 61 67 3135 3141 O
( 68 69 3142 3143 O
ages 69 73 3143 3147 B-age
18 74 76 3148 3150 B-lower_bound
- 76 77 3150 3151 O
65 77 79 3151 3153 B-upper_bound
years 80 85 3154 3159 I-upper_bound
old 86 89 3160 3163 O
) 89 90 3163 3164 O
have 91 95 3165 3169 O
been 96 100 3170 3174 O
treated 101 108 3175 3182 O
without 109 116 3183 3190 O
toxicity 117 125 3191 3199 O

